Advertisement
Advertisement

IONS

IONS logo

Ionis Pharmaceuticals, Inc. Common Stock

75.71
USD
Sponsored
-0.31
-0.41%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

75.71

0.00
0.00%

Ionis Pharmaceuticals, Inc. Common Stock Profile

About

Ionis Pharmaceuticals discovers/develops RNA-targeted therapeutics using its proprietary antisense oligonucleotide technology. Its antisense medicines have been developed/are being developed to treat neurological, cardiovascular and specialty rare diseases.

Info & Links

CEO

Brett P. Monia

Headquarters

2855 GAZELLE COURT
CARLSBAD, CA 92010, UNITED STATES

Industry

Medical Drugs

Sector

Medical

Website

https://ionis.com/

Auditor

Ernst & Young LLP

Share holders

412

Employees

1,402

Ionis Pharmaceuticals, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

12.51B

Enterprise Value

13.92B

Enterprise Value/EBITDA(ttm)

-37.04

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

13.37

Price to Book(mrq)

25.31

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

98.14%

Operating Margin(ttm)

-40.36%

Profit Margin(ttm)

-69.80%

Return on Equity(ttm)

-68.82%

Return on Invested Capital(ttm)

-21.77%

Return on Assets(ttm)

-12.34%

Income Statement

Revenue(ttm)

943.71M

Revenue Per Share(ttm)

5.71

Gross Profit(ttm)

927.80M

EBITDA(ttm)3

-375.82M

Net Income Available to Common(ttm)

-381.39M

Diluted EPS(ttm)

-2.44

Share Statistics

Beta (5Y Monthly)

0.40

52-Week Change

131.18%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

165.19M

Dividend Yield

0.00%

Float4

160.90M

% Held by Insiders

2.60%

% Held by Institutions

93.86%

Balance Sheet

Total Cash(mrq)

2.68B

Total Cash Per Share(mrq)

16.21

Total Debt(mrq)

1.78B

Total Debt/Equity(mrq)

363.82%

Current Ratio(mrq)

3.83%

Quick Ratio(mrq)

3.81%

Book Value Per Share(mrq)

2.99

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.68

Free Cash Flow(ytd)

-320.03M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement